Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 1 2014
Print

Breaking News

Related Searches:
October 14, 2010
Dr. Christel Fenge has been named vice president of marketing for Fermentation Technologies at Sartorius Stedim Biotech.   Read More »
October 14, 2010
Charles River Laboratories has entered into an exclusive, long-term marketing and distribution agreement with Transposagen Biopharmaceuticals, Inc., a KY-based provider of genetically modified rat models.   Read More »
October 13, 2010
Robert Davis has been appointed corporate vice president and president of Baxter International’s Medical Products business.  Read More »
October 13, 2010
Genmab has entered an agreement with H. Lundbeck to create and develop human antibody therapeutics for central nervous system (CNS) disorders for three targets identified by Lundbeck.  Read More »
October 13, 2010
PharmaBio Development Inc., the former strategic investing subsidiary of Quintiles, has agreed to purchase approximately 2.4 million shares of Discovery Laboratories, Inc. and approximately 1.2 million shares of common stock under a five-year term, for a   Read More »
October 12, 2010
Pfizer and King Pharmaceuticals, Inc. have entered into a definitive merger agreement under which Pfizer will acquire King for $3.6 billion in cash.  Read More »
October 12, 2010
David C. Lathbury, Ph.D. has been appointed vice president of chemical development at AMRI.   Read More »
October 12, 2010
Halozyme Therapeutics, Inc. has implemented a new drug development strategy and plans to decrease research relating to the discovery and preclinical development of new compounds.  Read More »
October 12, 2010
Indena’s Meriva has been awarded “Best New Product” of the year by a European outsourcing panel.  Read More »
October 12, 2010
BioStorage Technologies has expanded its sample management services to include laboratory sample preparation services.   Read More »
October 11, 2010
Exelixis, Inc. and Bristol-Myers Squibb have entered a collaboration agreement under which Exelixis will grant BMS an exclusive license to its small-molecule TGR5 agonist program, including backups.  Read More »
October 11, 2010
Philip J. Vickers, Ph.D., has been appointed senior vice president of R&D for Shire’s Human Genetic Therapies (HGT) business.   Read More »
October 11, 2010
Curis, Inc. and Genentech have initiated a Phase II trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).  Read More »
October 8, 2010
Takeda Pharmaceutical Co. Ltd. and Envoy Therapeutics, Inc., have formed a three-year research alliance aimed at discovering drugs for schizophrenia with greater efficacy and safety than current therapies.  Read More »
October 8, 2010
Joseph E. Cobb Jr., senior formulations scientist at Metrics Inc., has earned the Certified Pharmaceutical Industry Professional (CPIP) credential awarded by the ISPE Professional Certification Commission.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On